United States Biotechnology & Medical Research

Tarsus Pharmaceuticals, Inc. (TARS)

Track

Track

Tarsus Pharmaceuticals experienced significant insider trading activity over the past ninety days, totaling twenty-four transactions. Executives and directors executed sales worth approximately 25.5 million dollars. These divestments occurred following the most recent earnings report, while the stock price demonstrated a 22.2 percent increase during this period.
Ticker: TARS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tarsus Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
LINK WILLIAM J PHD Non-Executive Director
Transaction date
Planned sale
Price
265.02
Quantity 48,735 -33.0%
Value US$4,096,238
1.5
LINK WILLIAM J PHD Non-Executive Director
Transaction date
Planned sale
Price
290.61
Quantity 69,661 -4.2%
Value US$481,144
1.5
LINK WILLIAM J PHD Non-Executive Director
Transaction date
Planned sale
Price
77.48
Quantity 98,341 +4.5%
Value US$2,120,614
1.5
WILLIAM J LINK DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
78.38
Quantity 1,000
Value US$100,000
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
91.27
Quantity 1,000 -0.3%
Value US$100,000
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
90.27
Quantity 1,000 -0.8%
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 1,000 -50.0%
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.00
Quantity 1,000 -33.3%
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 1,000 -67.9%
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.00
Quantity 1,000 -40.4%
Value US$100,000
3.4
Neervannan Seshadri Chief Operating Officer Officer
Transaction date
Planned sale
Price
85.00
Quantity 1,000 -5.5%
Value US$100,000
3.5
BOBAK AZAMIAN OFFICER Officer
Transaction date
Proposed sale
Price
90.56
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
87.50
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Officer Officer
Transaction date
Proposed sale
Price
87.50
Quantity 1,000
Value US$100,000
3.4
Neervannan Seshadri Officer Officer
Transaction date
Proposed sale
Price
85.00
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
80.00
Quantity 1,000 -25.0%
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
80.00
Quantity 1,000 -28.8%
Value US$100,000
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
80.06
Quantity 1,000 -1.2%
Value US$100,000
3.6
Lin Elizabeth Yeu Member of immediate family of any of the foregoing
Transaction date
Proposed sale
Price
80.00
Quantity 1,000
Value US$100,000
3.5
Mottiwala Aziz Former Officer Officer
Transaction date
Proposed sale
Price
81.80
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Officer Officer
Transaction date
Proposed sale
Price
80.00
Quantity 1,000
Value US$100,000
3.5
BOBAK AZAMIAN OFFICER Officer
Transaction date
Proposed sale
Price
80.06
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Planned sale
Price
73.86
Quantity 1,000 -19.7%
Value US$100,000
3.5
Mottiwala Aziz Former Officer Officer
Transaction date
Proposed sale
Price
73.96
Quantity 1,000
Value US$100,000
3.6
Lin Elizabeth Yeu Officer Officer
Transaction date
Proposed sale
Price
73.86
Quantity 1,000
Value US$100,000
3.5
Mottiwala Aziz Former Officer Officer
Transaction date
Proposed sale
Price
71.85
Quantity 81,332
Value US$5,843,887
3.5
Mottiwala Aziz Former Officer Officer
Transaction date
Proposed sale
Price
72.00
Quantity 53,043
Value US$3,819,096
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
61.81
Quantity 5,418 -0.6%
Value US$334,887
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
61.81
Quantity 5,418 -0.6%
Value US$334,887
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
61.24
Quantity 4,582 -0.5%
Value US$280,602
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Planned sale
Price
61.24
Quantity 4,582 -0.5%
Value US$280,602
3.5
BOBAK AZAMIAN OFFICER Officer
Transaction date
Proposed sale
Price
61.55
Quantity 10,000
Value US$615,473
2.5
Farrow Jeffrey S See Remarks Officer
Transaction date
Sale
Price
60.95
Quantity 14,396 -20.2%
Value US$877,436
2.5
Farrow Jeffrey S Officer Officer
Transaction date
Proposed sale
Price
60.95
Quantity 14,396
Value US$877,459
1.5
LINK WILLIAM J PHD Non-Executive Director
Transaction date
Planned sale
Price
62.94
Quantity 1,928 -1.8%
Value US$121,348
1.5
LINK WILLIAM J PHD Non-Executive Director
Transaction date
Planned sale
Price
61.97
Quantity 10,572 -8.9%
Value US$655,147
Goodrich Katherine Non-Executive Director
Transaction date
Planned sale
Price
62.08
Quantity 2,954 -57.0%
Value US$183,384
1.5
William J Link Director Non-Executive Director
Transaction date
Proposed sale
Price
62.12
Quantity 12,500
Value US$776,498
Goodrich Katherine Director Non-Executive Director
Transaction date
Proposed sale
Price
62.08
Quantity 2,954
Value US$183,384
3.4
Neervannan Seshadri Chief Operating Officer Officer
Transaction date
Planned sale
Price
66.75
Quantity 2,989 -3.5%
Value US$199,516
3.4
Neervannan Seshadri Officer Officer
Transaction date
Proposed sale
Price
66.75
Quantity 2,989
Value US$199,516
3.2
Wahl Bryan General Counsel Officer
Transaction date
Sale
Price
67.00
Quantity 4,231 -6.2%
Value US$283,477
3.2
Whitfield Dianne C. Chief Human Resources Officer Officer
Transaction date
Sale
Price
67.00
Quantity 4,174 -10.6%
Value US$279,658
3.5
Mottiwala Aziz Chief Commercial Officer Officer
Transaction date
Sale
Price
67.00
Quantity 4,440 -6.7%
Value US$297,480
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Sale
Price
67.00
Quantity 390 -1.6%
Value US$26,130
2.5
Farrow Jeffrey S See Remarks Officer
Transaction date
Sale
Price
67.00
Quantity 2,186 -4.8%
Value US$146,462
3.4
Neervannan Seshadri Chief Operating Officer Officer
Transaction date
Sale
Price
67.00
Quantity 4,589 -5.1%
Value US$307,463
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Sale
Price
67.00
Quantity 11,964 -26.4%
Value US$801,588
2.5
Farrow Jeffrey S Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 2,186
Value US$146,459
3.5
Mottiwala Aziz Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 4,440
Value US$297,475
3.5
Azamian Bobak R. Officer; Director Executive Director
Transaction date
Proposed sale
Price
67.00
Quantity 11,964
Value US$801,574
3.2
Whitfield Dianne C. Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 4,174
Value US$279,653
3.2
Wahl Bryan Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 4,231
Value US$283,472
3.4
Neervannan Seshadri Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 4,589
Value US$307,457
3.6
Lin Elizabeth Yeu Officer Officer
Transaction date
Proposed sale
Price
67.00
Quantity 390
Value US$26,130
3.2
Wahl Bryan General Counsel Officer
Transaction date
Sale
Price
68.71
Quantity 4,125 -5.7%
Value US$283,429
3.2
Whitfield Dianne C. Chief Human Resources Officer Officer
Transaction date
Sale
Price
68.71
Quantity 4,071 -9.4%
Value US$279,718
3.5
Mottiwala Aziz Chief Commercial Officer Officer
Transaction date
Sale
Price
68.71
Quantity 4,330 -6.2%
Value US$297,514
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Sale
Price
68.71
Quantity 379 -1.6%
Value US$26,041
2.5
Farrow Jeffrey S See Remarks Officer
Transaction date
Sale
Price
68.71
Quantity 2,133 -4.5%
Value US$146,558
3.4
Neervannan Seshadri Chief Operating Officer Officer
Transaction date
Sale
Price
68.71
Quantity 3,610 -3.8%
Value US$248,043
3.5
Azamian Bobak R. President/CEO and Board Chair Executive Director
Transaction date
Sale
Price
68.71
Quantity 11,667 -20.4%
Value US$801,640
3.2
Whitfield Dianne C. Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 4,071
Value US$279,718
3.2
Wahl Bryan Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 4,125
Value US$283,428
3.5
Azamian Bobak R. Officer; Director Executive Director
Transaction date
Proposed sale
Price
68.71
Quantity 11,667
Value US$801,637
3.4
Neervannan Seshadri Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 3,610
Value US$248,042
3.6
Lin Elizabeth Yeu Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 379
Value US$26,041
2.5
Farrow Jeffrey S Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 2,133
Value US$146,558
3.5
Mottiwala Aziz Officer Officer
Transaction date
Proposed sale
Price
68.71
Quantity 4,330
Value US$297,513
3.2
Wahl Bryan General Counsel Officer
Transaction date
Sale
Price
69.42
Quantity 4,084 -5.3%
Value US$283,511
3.2
Whitfield Dianne C. Chief Human Resources Officer Officer
Transaction date
Sale
Price
69.42
Quantity 4,029 -8.5%
Value US$279,693
3.5
Mottiwala Aziz Chief Commercial Officer Officer
Transaction date
Sale
Price
69.42
Quantity 4,286 -5.8%
Value US$297,534
3.6
Lin Elizabeth Yeu Chief Medical Officer Officer
Transaction date
Sale
Price
69.42
Quantity 375 -1.5%
Value US$26,032
2.5
Farrow Jeffrey S See Remarks Officer
Transaction date
Sale
Price
69.42
Quantity 2,111 -4.2%
Value US$146,546
3.4
Neervannan Seshadri Chief Operating Officer Officer
Transaction date
Sale
Price
69.42
Quantity 3,125 -3.2%
Value US$216,938
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
48,735 -33.0%
265.02
US$4,096,238 		48,735 -33.0% 265.02 US$4,096,238
2026-09-17 2026-09-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
69,661 -4.2%
290.61
US$481,144 		69,661 -4.2% 290.61 US$481,144
2026-09-17 2026-09-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
98,341 +4.5%
77.48
US$2,120,614 		98,341 +4.5% 77.48 US$2,120,614
2026-09-15 2026-09-15 PrS Proposed sale
1.5
WILLIAM J LINK

DIRECTOR

Non-Executive Director
1,000
78.38
US$100,000 		1,000 78.38 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
1,000 -0.3%
91.27
US$100,000 		1,000 -0.3% 91.27 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
1,000 -0.8%
90.27
US$100,000 		1,000 -0.8% 90.27 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -50.0%
90.00
US$100,000 		1,000 -50.0% 90.00 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -33.3%
85.00
US$100,000 		1,000 -33.3% 85.00 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -67.9%
90.00
US$100,000 		1,000 -67.9% 90.00 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -40.4%
85.00
US$100,000 		1,000 -40.4% 85.00 US$100,000
2026-09-09 2026-09-04 PlS Planned sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
1,000 -5.5%
85.00
US$100,000 		1,000 -5.5% 85.00 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
3.5
BOBAK AZAMIAN

OFFICER

Officer
1,000
90.56
US$100,000 		1,000 90.56 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Member of immediate family of any of the foregoing
1,000
87.50
US$100,000 		1,000 87.50 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
1,000
87.50
US$100,000 		1,000 87.50 US$100,000
2026-09-04 2026-09-04 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
1,000
85.00
US$100,000 		1,000 85.00 US$100,000
2026-09-03 2026-09-02 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -25.0%
80.00
US$100,000 		1,000 -25.0% 80.00 US$100,000
2026-09-03 2026-09-02 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -28.8%
80.00
US$100,000 		1,000 -28.8% 80.00 US$100,000
2026-09-03 2026-09-02 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
1,000 -1.2%
80.06
US$100,000 		1,000 -1.2% 80.06 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Member of immediate family of any of the foregoing
1,000
80.00
US$100,000 		1,000 80.00 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
3.5
Mottiwala Aziz

Former Officer

Officer
1,000
81.80
US$100,000 		1,000 81.80 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
1,000
80.00
US$100,000 		1,000 80.00 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
3.5
BOBAK AZAMIAN

OFFICER

Officer
1,000
80.06
US$100,000 		1,000 80.06 US$100,000
2026-09-03 2026-09-01 PlS Planned sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
1,000 -19.7%
73.86
US$100,000 		1,000 -19.7% 73.86 US$100,000
2026-09-01 2026-09-01 PrS Proposed sale
3.5
Mottiwala Aziz

Former Officer

Officer
1,000
73.96
US$100,000 		1,000 73.96 US$100,000
2026-09-01 2026-09-01 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
1,000
73.86
US$100,000 		1,000 73.86 US$100,000
2026-08-25 2026-08-25 PrS Proposed sale
3.5
Mottiwala Aziz

Former Officer

Officer
81,332
71.85
US$5,843,887 		81,332 71.85 US$5,843,887
2026-08-19 2026-08-19 PrS Proposed sale
3.5
Mottiwala Aziz

Former Officer

Officer
53,043
72.00
US$3,819,096 		53,043 72.00 US$3,819,096
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
5,418 -0.6%
61.81
US$334,887 		5,418 -0.6% 61.81 US$334,887
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
5,418 -0.6%
61.81
US$334,887 		5,418 -0.6% 61.81 US$334,887
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
4,582 -0.5%
61.24
US$280,602 		4,582 -0.5% 61.24 US$280,602
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
4,582 -0.5%
61.24
US$280,602 		4,582 -0.5% 61.24 US$280,602
2026-06-17 2026-06-17 PrS Proposed sale
3.5
BOBAK AZAMIAN

OFFICER

Officer
10,000
61.55
US$615,473 		10,000 61.55 US$615,473
2026-06-17 2026-06-16 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
14,396 -20.2%
60.95
US$877,436 		14,396 -20.2% 60.95 US$877,436
2026-06-16 2026-06-16 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
14,396
60.95
US$877,459 		14,396 60.95 US$877,459
2026-06-17 2026-06-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
1,928 -1.8%
62.94
US$121,348 		1,928 -1.8% 62.94 US$121,348
2026-06-17 2026-06-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
10,572 -8.9%
61.97
US$655,147 		10,572 -8.9% 61.97 US$655,147
2026-06-17 2026-06-15 PlS Planned sale
Goodrich Katherine
Non-Executive Director
2,954 -57.0%
62.08
US$183,384 		2,954 -57.0% 62.08 US$183,384
2026-06-15 2026-06-15 PrS Proposed sale
1.5
William J Link

Director

Non-Executive Director
12,500
62.12
US$776,498 		12,500 62.12 US$776,498
2026-06-15 2026-06-15 PrS Proposed sale
Goodrich Katherine

Director

Non-Executive Director
2,954
62.08
US$183,384 		2,954 62.08 US$183,384
2026-03-24 2026-03-20 PlS Planned sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
2,989 -3.5%
66.75
US$199,516 		2,989 -3.5% 66.75 US$199,516
2026-03-20 2026-03-20 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
2,989
66.75
US$199,516 		2,989 66.75 US$199,516
2026-03-19 2026-03-19 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,231 -6.2%
67.00
US$283,477 		4,231 -6.2% 67.00 US$283,477
2026-03-19 2026-03-19 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,174 -10.6%
67.00
US$279,658 		4,174 -10.6% 67.00 US$279,658
2026-03-19 2026-03-19 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,440 -6.7%
67.00
US$297,480 		4,440 -6.7% 67.00 US$297,480
2026-03-19 2026-03-19 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
390 -1.6%
67.00
US$26,130 		390 -1.6% 67.00 US$26,130
2026-03-19 2026-03-19 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,186 -4.8%
67.00
US$146,462 		2,186 -4.8% 67.00 US$146,462
2026-03-19 2026-03-19 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
4,589 -5.1%
67.00
US$307,463 		4,589 -5.1% 67.00 US$307,463
2026-03-19 2026-03-19 S Sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
11,964 -26.4%
67.00
US$801,588 		11,964 -26.4% 67.00 US$801,588
2026-03-19 2026-03-19 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
2,186
67.00
US$146,459 		2,186 67.00 US$146,459
2026-03-19 2026-03-19 PrS Proposed sale
3.5
Mottiwala Aziz

Officer

Officer
4,440
67.00
US$297,475 		4,440 67.00 US$297,475
2026-03-19 2026-03-19 PrS Proposed sale
3.5
Azamian Bobak R.

Officer; Director

Executive Director
11,964
67.00
US$801,574 		11,964 67.00 US$801,574
2026-03-19 2026-03-19 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
4,174
67.00
US$279,653 		4,174 67.00 US$279,653
2026-03-19 2026-03-19 PrS Proposed sale
3.2
Wahl Bryan

Officer

Officer
4,231
67.00
US$283,472 		4,231 67.00 US$283,472
2026-03-19 2026-03-19 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
4,589
67.00
US$307,457 		4,589 67.00 US$307,457
2026-03-19 2026-03-19 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
390
67.00
US$26,130 		390 67.00 US$26,130
2026-03-19 2026-03-18 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,125 -5.7%
68.71
US$283,429 		4,125 -5.7% 68.71 US$283,429
2026-03-19 2026-03-18 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,071 -9.4%
68.71
US$279,718 		4,071 -9.4% 68.71 US$279,718
2026-03-19 2026-03-18 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,330 -6.2%
68.71
US$297,514 		4,330 -6.2% 68.71 US$297,514
2026-03-19 2026-03-18 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
379 -1.6%
68.71
US$26,041 		379 -1.6% 68.71 US$26,041
2026-03-19 2026-03-18 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,133 -4.5%
68.71
US$146,558 		2,133 -4.5% 68.71 US$146,558
2026-03-19 2026-03-18 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
3,610 -3.8%
68.71
US$248,043 		3,610 -3.8% 68.71 US$248,043
2026-03-19 2026-03-18 S Sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
11,667 -20.4%
68.71
US$801,640 		11,667 -20.4% 68.71 US$801,640
2026-03-18 2026-03-18 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
4,071
68.71
US$279,718 		4,071 68.71 US$279,718
2026-03-18 2026-03-18 PrS Proposed sale
3.2
Wahl Bryan

Officer

Officer
4,125
68.71
US$283,428 		4,125 68.71 US$283,428
2026-03-18 2026-03-18 PrS Proposed sale
3.5
Azamian Bobak R.

Officer; Director

Executive Director
11,667
68.71
US$801,637 		11,667 68.71 US$801,637
2026-03-18 2026-03-18 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
3,610
68.71
US$248,042 		3,610 68.71 US$248,042
2026-03-18 2026-03-18 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
379
68.71
US$26,041 		379 68.71 US$26,041
2026-03-18 2026-03-18 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
2,133
68.71
US$146,558 		2,133 68.71 US$146,558
2026-03-18 2026-03-18 PrS Proposed sale
3.5
Mottiwala Aziz

Officer

Officer
4,330
68.71
US$297,513 		4,330 68.71 US$297,513
2026-03-19 2026-03-17 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,084 -5.3%
69.42
US$283,511 		4,084 -5.3% 69.42 US$283,511
2026-03-19 2026-03-17 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,029 -8.5%
69.42
US$279,693 		4,029 -8.5% 69.42 US$279,693
2026-03-19 2026-03-17 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,286 -5.8%
69.42
US$297,534 		4,286 -5.8% 69.42 US$297,534
2026-03-19 2026-03-17 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
375 -1.5%
69.42
US$26,032 		375 -1.5% 69.42 US$26,032
2026-03-19 2026-03-17 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,111 -4.2%
69.42
US$146,546 		2,111 -4.2% 69.42 US$146,546
2026-03-19 2026-03-17 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
3,125 -3.2%
69.42
US$216,938 		3,125 -3.2% 69.42 US$216,938
Explore more

More insider trading research around Tarsus Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America